Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Mechanically-Modulated Genes in Cardiac Myocytes

Cardiovascular Drugs and Therapy

Volumn 17, Issue 3, 2003, Pages 231-236

  Ohki, Ruri ^a   Yamamoto, Keiji ^a   Ueno, Shuichi ^a   Mano, Hiroyuki ^a   Ikeda, Uichi ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Cardiac; Gene expression; Mechanical; Myocyte; Stress

Indexed keywords

ACUTE PHASE PROTEIN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CS 886; DRUG METABOLITE; ION; ION CHANNEL; MESSENGER RNA; NEUROMEDIN B; OLMESARTAN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN BCL X; RECEPTOR; RETINOL BINDING PROTEIN; RNH 6270 R; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DETOXIFICATION; DNA MICROARRAY; DRUG EFFECT; EXPRESSED SEQUENCE TAG; GENE; GENE EXPRESSION; GENE INDUCTION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; GENOME; HEART MUSCLE CELL; MECHANICAL STIMULATION; MECHANICAL STRESS; MEMBRANE; METABOLISM; MODULATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY RECEPTOR; PRIORITY JOURNAL; RAT; RNA ISOLATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; IMIDAZOLES; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, MECHANICAL; TETRAZOLES;

EID: 0242637235     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026120123461     Document Type: Article

References (30)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
3. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-677.
4. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992;117:234-242.
5. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-1654.
6. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-1675.
7. Yanagisawa H, Amemiya Y, Kanazaki T, et al. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds. J Med Chem 1996;39:323-338.
8. Mizuno M, Sada T, Ikeda M, et al. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol 1995;285:181-188.
9. Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999;283:83-87.
10. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000;86:939-945.
11. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 2000;97:6745-6750.
12. Yang J, Moravec CS, Sussman MA, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000;102:3046-3052.
13. Springhorn JP, Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 1989;258:73-78.
14. Cheng GC, Briggs WH, Gerson DS, et al. Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ Res 1997;80:28-36.
15. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-1680.
16. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res 1996;6:986-994.
17. Kruse N, Pette M, Toyka K, et al. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J Immunol Methods 1997;210:195-203.
18. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-1680.
19. Cole T, Inglis AS, Roxburgh CM, Howlett GJ, Schreiber G. Major acute phase alpha 1-protein of the rat is homologous to bovine kininogen and contains the sequence for bradykinin: its synthesis is regulated at the mRNA level. FEBS Lett 1985;182:57-61.
20. Minamino N, Kangawa K, Matsuo H. Neuromedin B: A novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophy Res Commun 1983;114:541-548.
21. Cuttitta F, Carney DN, Mulshine J, et al. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 1985;316:823-825.
22. Moody TW, Jensen RT, Garcia L, Leyton J. Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells. Eur J Pharmacol 2000;409:133-142.
23. Snyder MJ, Mulder EP. Environmental endocrine disruption in decapod crustacean larvae: hormone titers, cytochrome P450, and stress protein responses to heptachlor exposure. Aquat Toxicol 2001;55:177-190.
24. Rodrigues-Lima F, Delomenie C, Goodfellow GH, Grant DM, Dupret JM. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: Evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem J 2001;356:327-334.
25. Ling S, Deng G, Ives HE, et al. Estrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1. Cardiovasc Res 2001;50:108-114.
26. Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999;84:1127-1136.
27. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
28. Shiraiwa N, Inohara N, Okada S, Yuzaki M, Shoji S, Ohta S. An additional form of rat Bcl-x, Bcl-xbeta, generated by an unspliced RNA, promotes apoptosis in promyeloid cells. J Biol Chem 1996;271:13258-13265.
29. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-1587.
30. Schwocho LR, Masonson HN. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 2001;41:515-527.